| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/BI980832Y |
| P698 | PubMed publication ID | 9753474 |
| P2093 | author name string | H Williams | |
| J Parsons | |||
| B Frantz | |||
| S J O'Keefe | |||
| M Pang | |||
| E A O'Neill | |||
| A Rolando | |||
| M J Tocci | |||
| T Klatt | |||
| P433 | issue | 39 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 13846-13853 | |
| P577 | publication date | 1998-09-01 | |
| P1433 | published in | Biochemistry | Q764876 |
| P1476 | title | The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding | |
| P478 | volume | 37 |
| Q44650493 | 12-O-tetradecanoylphorbol-13-acetate may both potentiate and decrease the generation of apoptosis by the antileukemic agent arsenic trioxide in human promonocytic cells. Regulation by extracellular signal-regulated protein kinases and glutathione |
| Q27667388 | A Novel Mode of Protein Kinase Inhibition Exploiting Hydrophobic Motifs of Autoinhibited Kinases: DISCOVERY OF ATP-INDEPENDENT INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR |
| Q43707863 | Activation of multiple MAPK pathways (ERKs, JNKs, p38-MAPK) by diverse stimuli in the amphibian heart |
| Q44035200 | Activation of p38 mitogen-activated protein kinase during normal mitosis in the developing retina |
| Q40188544 | Activation of p38MAPK by repetitive low-grade oxidative stress leads to pro-survival effects |
| Q40525596 | Basic fibroblast growth factor-induced cell death is effected through sustained activation of p38MAPK and up-regulation of the death receptor p75NTR. |
| Q38818757 | Changes in the free-energy landscape of p38α MAP kinase through its canonical activation and binding events as studied by enhanced molecular dynamics simulations |
| Q35119780 | Chemical enhancement in embryo development and stem cell derivation from single blastomeres |
| Q54408821 | Cycloheximide and lipopolysaccharide downregulate αENaC mRNA via different mechanisms in alveolar epithelial cells. |
| Q44748189 | Deoxynivalenol induces p38 interaction with the ribosome in monocytes and macrophages. |
| Q31733291 | Development of a p38 Kinase Binding Assay for High Throughput Screening |
| Q28301932 | Differential regulation and properties of MAPKs |
| Q28484258 | Discovery of novel orally active anti-inflammatory N-phenylpyrazolyl-N-glycinyl-hydrazone derivatives that inhibit TNF-α production |
| Q50711800 | Downregulation of human endothelial nitric oxide synthase promoter activity by p38 mitogen-activated protein kinase activation. |
| Q46487836 | ERK1/2 and p38 regulate trophoblasts differentiation in human term placenta. |
| Q40422294 | Escherichia coli K1 inhibits proinflammatory cytokine induction in monocytes by preventing NF-kappaB activation |
| Q39154885 | From Type I to Type II: Design, Synthesis, and Characterization of Potent Pyrazin-2-ones as DFG-Out Inhibitors of PDGFRβ. |
| Q37434800 | Hydrogen-exchange mass spectrometry reveals activation-induced changes in the conformational mobility of p38alpha MAP kinase |
| Q45029417 | Hyperosmotically induced accumulation of a phosphorylated p38-like MAPK involved in protoplast volume regulation of plasmolyzed wheat root cells |
| Q40015902 | Hypoxia modulates lipopolysaccharide induced TNF-alpha expression in murine macrophages. |
| Q27681692 | Identification of type-II inhibitors using kinase structures |
| Q43260381 | Induction of uncoupling protein-1 in mouse embryonic fibroblast-derived adipocytes by retinoic acid |
| Q33957191 | Inhibition of p38 MAP kinase as a therapeutic strategy |
| Q42668405 | Inhibition of p38 MAPK reverses hypoxia-induced pulmonary artery endothelial dysfunction |
| Q35903480 | Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids |
| Q43635650 | Inhibition of p38MAP kinase potentiates the JNK/SAPK pathway and AP-1 activity in monocytic but not in macrophage or granulocytic differentiation of HL60 cells |
| Q51769536 | Integrating targeted gene expression and a skin model system to identify functional inhibitors of the UV activated p38 MAP kinase. |
| Q42435286 | Involvement of p38 MAPK in haemozoin-dependent MMP-9 enhancement in human monocytes |
| Q40840061 | Involvement of the p38 mitogen-activated protein kinase pathway in tissue inhibitor of metalloproteinases-1-induced erythroid differentiation |
| Q24569633 | Isoforms of p38MAPK gamma and delta contribute to differentiation of human AML cells induced by 1,25-dihydroxyvitamin D₃ |
| Q52592660 | Kinetics of small molecule inhibitor binding to p38 kinase. |
| Q34301358 | Label-free microscale thermophoresis discriminates sites and affinity of protein-ligand binding |
| Q29619955 | MAPK cascade signalling and synaptic plasticity |
| Q54612121 | Mallory body (cytokeratin aggresomes) formation is prevented in vitro by p38 inhibitor. |
| Q40241352 | Mitogen-activated protein kinase (MAPK) signalling pathways in HepG2 cells infected with a virulent strain of Klebsiella pneumoniae |
| Q37052050 | Molecular basis of oncostatin M-induced SOCS-3 expression in astrocytes |
| Q43823964 | Osmoregulation of natriuretic peptide receptor signaling in inner medullary collecting duct. A requirement for p38 MAPK. |
| Q64067609 | P38 inhibition reverses TGFβ1 and TNFα-induced contraction in a model of proliferative vitreoretinopathy |
| Q42829916 | Pharmacologic inhibitors of MKK1 and MKK2. |
| Q34502720 | Pharmacological inhibitors of MAPK pathways. |
| Q73088396 | Phorbol ester induced MDR1 expression in K562 cells occurs independently of mitogen-activated protein kinase signaling pathways |
| Q37255436 | Phosphorylation of BlaR1 in Manifestation of Antibiotic Resistance in Methicillin-Resistant Staphylococcus aureus and Its Abrogation by Small Molecules |
| Q39668225 | Platelet‐Derived Growth Factor‐BB Stimulated Cell Migration Mediated Through p38 Signal Transduction Pathway in Periodontal Cells |
| Q34432247 | Polyphenol fraction of extra virgin olive oil protects against endothelial dysfunction induced by high glucose and free fatty acids through modulation of nitric oxide and endothelin-1. |
| Q48600559 | Possible role of p38 MAPK-MNK1-EMI2 cascade in metaphase-II arrest of mouse oocytes |
| Q30659829 | RNA aptamers as pathway-specific MAP kinase inhibitors |
| Q35819217 | ROS-Induced JNK and p38 Signaling Is Required for Unpaired Cytokine Activation during Drosophila Regeneration |
| Q43656785 | Regulated ARE-mediated mRNA decay in Saccharomyces cerevisiae |
| Q58806000 | Regulation of Cyclooxygenase-2 Induction in the Mouse Uterus During Decidualization |
| Q44348326 | Regulation of MAPK pathways in response to purinergic stimulation of adult rat cardiac myocytes |
| Q40912879 | Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress. Evidence for cross-talk between the insulin and SAPK2/p38 mitogen-activated protein kinase signaling pathways |
| Q40730540 | Ro 31-6045, the inactive analogue of the protein kinase C inhibitor Ro 31-8220, blocks in vivo activation of p70(s6k)/p85(s6k): implications for the analysis of S6K signalling. |
| Q44875714 | Role of p38 MAPK in LPS induced pro-inflammatory cytokine and chemokine gene expression in equine leukocytes. |
| Q39205419 | S. aureus haemolysin A-induced IL-8 and IL-6 release from human airway epithelial cells is mediated by activation of p38- and Erk-MAP kinases and additional, cell type-specific signalling mechanisms |
| Q37466941 | SD0006: a potent, selective and orally available inhibitor of p38 kinase |
| Q33905886 | Selective activation of p38 MAPK cascade and mitotic arrest caused by low level oxidative stress |
| Q40221927 | Species and response dependent differences in the effects of MAPK inhibitors on P2X(7) receptor function |
| Q28344791 | Specificity and mechanism of action of some commonly used protein kinase inhibitors |
| Q45305579 | Suppression of MAPK11 or HIPK3 reduces mutant Huntingtin levels in Huntington's disease models |
| Q88389134 | TGF-β-target genes are differentially regulated in corneal epithelial cells and fibroblasts |
| Q36208936 | TSLP signaling network revealed by SILAC-based phosphoproteomics |
| Q33695725 | The development and therapeutic potential of protein kinase inhibitors |
| Q33302017 | The involvement of a P38-like MAP kinase in ABA-induced and H2O2-mediated stomatal closure in Vicia faba L. |
| Q36518938 | The many paths to p38 mitogen-activated protein kinase activation in the immune system |
| Q40858871 | The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway |
| Q36423252 | The p38 mitogen-activated protein kinase signaling cascade in CD4 T cells |
| Q39755299 | The p38 signaling pathway upregulates expression of the Epstein-Barr virus LMP1 oncogene |
| Q28513382 | The role of ATF-2 family transcription factors in adipocyte differentiation: antiobesity effects of p38 inhibitors |
| Q35688212 | The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression |
| Q44870828 | The role of p38 mitogen-activated kinase (MAPK) in the mechanism regulating cyclooxygenase gene expression in equine leukocytes. |
| Q45070681 | Therapeutic Innovations: Tyrosine Kinase Inhibitors in Cancer |
| Q34483284 | p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines. |
| Q28678986 | p38 MAPK signalling cascades in inflammatory disease |
| Q33716182 | p38 mitogen-activated protein kinase inhibitors--mechanisms and therapeutic potentials |
| Q39362199 | p38β MAP kinase as a therapeutic target for pancreatic cancer |
Search more.